We are dedicated to creating a world with a cure for rhabdomyosarcoma (RMS), as well as improving outcomes for those with this and other pediatric sarcomas.

We fund research into understanding, treating, and ultimately curing RMS and other pediatric sarcomas, which are rare and often fatal types of cancer that primarily affect children as well as young adults.